MedTrace Logo

An Observational Study of First-Line Capecitabine Based Chemotherapy in Participants With Metastatic Colorectal Cancer

NCT01696695 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 882

Last updated 2017-03-23

Study results available
· View outcomes & findings →

Summary

This observational study will evaluate the efficacy and safety of different capecitabine based chemotherapies, alone or in combination with other therapies, as first line treatment of metastatic colorectal cancer in participants during everyday clinical practice.

Conditions

Interventions

DRUG

Capecitabine

First line capecitabine based oral tablet treatment in line with the effective Summary of Product Characteristics

DRUG

Chemotherapy

First line chemotherapy according to effective official Summary of Product Characteristics. The study protocol does not specify any particular therapy.

Sponsors & Collaborators

Principal Investigators

  • Clinical Trials · Hoffmann-La Roche

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • Hungary

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01696695 on ClinicalTrials.gov